ACLF—Contrasting Perspectives From the East and West

Acute-on-chronic liver failure (ACLF) is a severe condition characterized by acute decompensation in patients with chronic liver disease, accompanied by organ failures and high short-term mortality. However, the definitions, triggers, and management strategies for ACLF differ significantly between Eastern (Asia–Pacific) and Western perspectives. Below is a detailed comparison of the contrasting approaches from the East and West:

---

1. Definitions: APASL vs AASLD/CLIF

Eastern Perspective: APASL (Asia–Pacific Association for the Study of the Liver)

• Definition: ACLF is primarily defined as an acute hepatic insult in a patient with chronic liver disease or compensated cirrhosis. This insult leads to:
• Jaundice (bilirubin ≥5 mg/dL)
• Coagulopathy (INR ≥1.5)
• Complications within 4 weeks, including ascites and/or encephalopathy.
• Focus: Liver failure is considered the primary event, with extrahepatic organ dysfunction being secondary.
• Triggers: Common acute hepatic insults include:
• Flare of hepatitis B virus (HBV)
• Acute alcoholic hepatitis
• Drug-induced liver injury
• Infection
• Approach: The definition emphasizes liver-centric failure and its progression to multi-organ dysfunction.

Western Perspective: AASLD/CLIF (American Association for the Study of Liver Diseases / Chronic Liver Failure Consortium)

• Definition: ACLF is defined in patients with decompensated cirrhosis based on the presence of organ failures, assessed using:
• CLIF-SOFA/CLIF-OF score, which evaluates:
• Liver function
• Kidney function
• Brain function
• Coagulation
• Circulation
• Respiration
• Associated 28-day mortality risk is a key component of the definition.
• Focus: ACLF is considered a multiorgan failure syndrome in cirrhosis, where organ dysfunctions occur simultaneously.
• Triggers: Common triggers include:
• Infection (e.g., spontaneous bacterial peritonitis)
• Active alcohol use
• Gastrointestinal bleeding
• Approach: The definition highlights systemic involvement and multiorgan failure.

---

2. Management: East vs West

Western Perspective: AASLD/EASL-CLIF

• Early ICU-Level Care: Patients with ACLF are often admitted to intensive care units for close monitoring and aggressive interventions.
• Sepsis Control: Infection is a frequent trigger, and early, aggressive management of sepsis is emphasized.
• Renal Replacement Therapy (RRT): For acute kidney injury or hepatorenal syndrome.
• Vasopressors: Used to manage circulatory dysfunction and maintain hemodynamic stability.
• Transplantation: There is a strong emphasis on early liver transplant evaluation. The approach follows a "transplant or die" paradigm for high-grade ACLF, as transplantation is often the definitive treatment for survival.
• Focus: Systemic support and transplant-centered care.

Eastern Perspective: APASL

• Medical Management and Liver Regeneration:
• Antiviral Therapy: For HBV flares, antiviral agents are used to control the underlying hepatic insult.
• Albumin Infusions: To improve circulatory dysfunction and reduce inflammation.
• Plasma Exchange: Used in some centers to support liver function and remove toxins.
• Stem-Cell/Regenerative Therapies: Experimental approaches are employed in select centers to promote liver regeneration.
• Transplantation: While liver transplantation is important, access to transplantation is often limited in resource-constrained settings. As a result, there is greater focus on bridging and rescue therapies.
• Focus: Liver-centric management and regeneration-friendly approaches.

---

3. Why This Contrast Matters

Understanding the differences between Eastern and Western approaches to ACLF is crucial for a comprehensive perspective on the disease. Here’s why:

Recognition of ACLF Across Different Etiologies

• In Asia, HBV-related ACLF is more prevalent, whereas alcohol-related ACLF and metabolic dysfunction-associated liver disease (MASLD, formerly NAFLD) are more common in the West.
• Recognizing the specific triggers and etiologies helps tailor early diagnosis and interventions.

Adaptation to Resource-Limited Settings

• In regions where liver transplantation is not readily available, Eastern approaches focus on medical management and regenerative therapies as alternatives to transplantation.
• Western approaches, on the other hand, emphasize transplantation as the definitive treatment for ACLF.

Convergence Toward Unified Management

• Both Eastern and Western perspectives are gradually converging toward a phenotype-based, transplant-aware approach to ACLF.
• There is growing interest in combining liver regeneration strategies with systemic support for multiorgan failure.

---

Conclusion

The contrasting perspectives from the East and West highlight the complexity of ACLF as a global health challenge. While the East focuses on liver-centric mechanisms and regeneration, the West emphasizes systemic multiorgan failure and transplantation. Understanding these differences enables clinicians to:

• Recognize ACLF early, regardless of etiology.
• Adapt management strategies based on available resources.
• Work toward a unified, patient-centered approach to ACLF care.